HIV Flashcards

1
Q

HIV-1

A
  • Responsible for most cases of AIDS in the US
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Antigenicically disntinct genotypes of HIV-1

A
  • Groups M, O, N, P
  • Group M is responsible for the global AIDS epidemic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Group M HIV genotype

A
  • Based on sequence differences of env and gag genes
  • results in antigenicity differences b/w gp120 and capsid proteins
  • Subtype B predominates in US
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Clades definition

A
  • Varying subtypes of a gene
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Essential genes (all retroviruses)

A
  • gag (group antigens) gene
  • pol (polymerase) gene
  • env (envelope) gene
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Gag gene

A
  • Essential gene of retroviruses
  • Encodes:

*matrix protein (p17)

*capsid protein (p24)

*nucleocapsid (p9)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Pol gene

A
  • Essential gene of retroviruses
  • Encodes:

*protease (p10)

*reverse transcriptase (p50)

*RNase (p15)

*integrase (p31)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Env gene

A
  • Essential gene of retroviruses
  • Encodes:

*surface subunit (gp120)

*transmembrane subunit (gp41)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

HIV regulatory (accessory) genes

A
  • tat
  • rev
  • nef
  • vif
  • vpu
  • vpr
  • These genes enhance the replication and infectivity to counter some host defense mechanisms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Tat gene

A
  • HIV regulatory gene
  • transactivates transcription of HIV genes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Rev gene

A
  • HIV regulatory gene
  • regulates RNA splicing and promotes export of mRNA to the cytoplasm
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Nef gene

A
  • HIV regulatory gene
  • Reduces cell surface expression of CD4 and MHC class I; alters T cell signaling pathways; required to maintain high viral loads; essential for progression to AIDS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Vif gene

A
  • HIV regulatory gene
  • Promotes assembly; blocks a cellular antiviral protein that produces hypermutations during cDNA transcription
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Vpu gene

A
  • HIV regulatory gene
  • Facilitates release of virus by countering a cellular protein that tethers virions to the infected cell; induces degradation of cell surface CD4
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Vpr gene

A
  • HIV regulatory gene
  • Transports cDNA to the nucleus; induces cell cycle arrest; facilitates replication in myeloid cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Long Terminal Repeats (LTR)

A
  • On either end of the HIV genome
  • Contains promoters and sequences used as binding sites by transcription factors
  • Activated cells produce transcription factors that bind LTR and activate transcription of viral genes

- Activated T cells can be productively infected by HIV and generate progeny virions

- Resting T cells are not productively infected by HIV

*incomplete viral cDNA transcripts accumulate or

*proviral DNA is made but does not integrate into the host chromosome (pre-integration latency)

17
Q

HIV replication outline

A
  • Viral attachment and entry
  • Genomic RNA reverse transcribed into cDNA
  • cDNA enter the nucleus and integrates into host chromosomes
  • Transcription/translation of genes from the proviral DNA template
  • Assembly of a premature particle and budding through the plasma membrane
  • Maturation into infectious virus
18
Q

HIV Attachment and entry

A
  • Host cell receptors:

*CD4; primary co-receptor to HIV gp120

*chemokine receptors (CCR-5, CXCR-4); primary co-receptor to HIV gp120

*alpha-4 beta-7 integrin (GALT homing receptor for activated T-cells)

*DC-SIGN (intercellular adhesion molecule on dendritic cells)

  • Viral attachment

*gp120

  • Entry

*virus-cell fusion at the plasma membrane

*receptor-mediated endocytosis- fusion at the endosomal membrane

*mediated by gp41 (activated only when both co-receptors (CD4, chemokine) are bound by HIV ligand (gp120)

19
Q

Assembly and Maturation of HIV

A
  • Assembly at the cell surface

*gag and gag-pol polyprotein precursors package viral RNA genome

  • Budding through the cell membrane

*acquires lipid envelope w/gp120 and gp41

  • Maturation into infectious virus

*HIV protease cleaves gag and gag-pol polyprotein into individual proteins- changes the viral particle into a fully infectious one

*protease inhibitors inhibit this processing so mature proteins are not produced

20
Q

Classes of antiretrovirals

A
  • Nucleoside reverse transcriptase inhibitors (NRTIs); nucleoside analogues
  • Non-nucleoside reverse transcriptase inhibitors (NNRTI)
  • Protease inhibitors
  • Attachment/Entry inhibitors

*fusion inhibitors

*CCR5 inhibitor

  • Integrase inhibitors
21
Q

Nucleoside reverse transcriptase inhibitors

A
  • Zidovudine (azidothymidine or AZT)
  • Requires phosphorylation for activation

*cellular enzymes carry out all 3 phosphorylation steps

  • The activated drug binds to and inhibits RT
  • Incorporation into the DNA strand results in chain termination
  • Resistance is due to mutations in the HIV RT

*encoded by the pol gene

22
Q

Non-nucleoside reverse transcriptase inhibitors

A
  • Nevirapine
  • Does not require phosphorylation for activation
  • Bind to RT at a site distinct from the active site, but inhibit its activity
  • Inhibit HIV-1 RT, but not HIV-2 RT
  • Resistance is due to mutations in RT, distinct from those responsible for resistance to NRTIs
23
Q

Protease inhibitors

A
  • Saquinavir
  • Small molecules that bind in the enzymatic pocket of HIV protease
  • Inhibition of the protease inhibits the maturation of infectious viral particles
  • Resistance is due to mutations in the protease (pol gene)

*cross resistance b/w protease inhibitors is common

24
Q

Fusion inhibitors

A
  • Enfuvirtide
  • 36 amino acid peptide that binds to gp41
  • Blocks the conformational change that occurs after gp120 bind to CD4
  • gp41 is unable to mediate fusion b/w the viral envelope and the host cell membrane

*entry is inhibited

  • Resistance will occur if HIV mutates the binding site of enfuvirtide
25
CCR5 inhibitor
- **Maraviroc** - Binds CCR5 and alters its conformation - Inhibits HIV binding to CCR5 - **NOTE: this antiretroviral binds to a host protein** - Mechanisms of resistance: \*HIV develops affinity for CXCR4 chemokine receptors \*pre-existing variants that use CXCR4 will be selected for \*HIV develops affinity for the drug-bound CCR5 conformation
26
Integrase inhibitors
- Raltegravir (Isentress and MK-0518) - MOA: \*integrase binds to the ends of the DNA provirus and helps to form the "preintegration complex" (PIC) \*it cleaves two nucleotides from each 3' end of the provirus and then binds to host cell's DNA \*it catalyzes a covalent joining (strand transfer) of the viral DNA 3' ends to the cell's DNA- inhibited by **raltegavir** **\***the gaps are filled, presumably w/a host enzyme
27
Points about antiretroviral therapy
- Antiretroviral drugs disrupt productive infection, not latent - While antirretroviral therapy inhibits active viral replication, it provides selective pressure for drug resistance - Latency/sporadic reactivation from viral reservoirs makes it unlikely that HIV will be completely cleared from an infected individual \*multidrug resistance will not develop during latency
28
HIV infection of CD4 T cells
- Productive infection in activated CD4 T cells \*loss of CD4 T cells via direct HIV-induced cell lysis or apoptosis or CD8- mediated cell killing (1/2 life about 0.5 days) - Nonproductive infection of resting CD4 T cells \*pre-integration latency- short term HIV reservoir \*impaired reverse transcription results in accumulation of incomplete viral cDNA transcripts \*cDNA transcripts trigger an inflammatory form of cell suicide (pyroptosis) - Post-integration latency \*proviral DNA integrates into host chromosomes \*T cells differentiate into memory cells-**long term HIV reservoir**
29
Viral Reservoirs
- Short term reservoirs \*pre-integration latency in resting CD4 T cells \*extracellular virus particles trapped on follicular dendritic cells \*productive, persistent infection of monocyte-macrophage lineage cells \*latent infection of monocyte-macrophage lineage cells - Long term reservoir \*post-integration latency in memory CD4+ T cells
30
Early stages of HIV infection
- **R5 viruses** \*binds **CCR-5** chemokine receptors \*responsible for majority of viral transmission \*nonsyncytia-inducing strains (NSI) \*macrophage tropic- previous designation - R5 viruses persist throughout the infection - Quasispecies appear after viremia peaks \*closely related viral genomes; have some variability \*result of point mutations within the viral genome
31
Late stages of HIV infection
- **X4 viruses** \*binds **CXCR-4** chemokine receptors \*occurs in about 50% of patients \*syncytia-inducing strains (SI); **more cytopathic** \*involves acquiring point mutations in the env gene - Some viruses use both co-receptors (R5X4) \*occurs in later stage patients
32
Course of HIV infection general overview chart
33
Clinical Latency
- Immune response limits the productive infection, but doesn't eliminate it \*productive infection still occurs (lymph nodes) \*steady state viral load until T cells are depleted; viral set pint - Persistent, low level productive infection \*macrophages; dendritic cells etc. - Latent infection \*memory T cell \*possibly monocyte lineage cells including hematopoietic stem cells \*can reactivate =\> productive infection - Dont have AIDS at clinical latency; you are HIV+; you dont have AIDS until your immune system has been compromised to the point where you are developing opportunistic infections (\<200 CD4 T cells in a mircoliter) NOTE: clinical latency in an HIV+ individual is not the same as viral latency at the cellular level
34
Acute Infection
- Typically 2-4 wks after exposure - Mononucleosis-like syndrome \*T cell proliferation to try to clear virus \*viral levels in blood drop, but virus is not completely cleared \*virus persists in lymph nodes \*microglial cells in the CNS - Typically assoc. w/R5 virus - ~80% mucosal transmission- HIV infections are due to a single virus (**founder virus**) - HIV bind to dendritic cells; taken to lymph nodes \*binding mediated by DC-SIGN \*presented to CD4 T cells by dendritic cells \*HIV internalized by DCs; spread to CD4 T cells - Loss of CD4 T cells within mucosal-assoc. lymphoid tissue (especially GALT) \*extensive depletion of CD4+ CCR5+ memory T cells in GALT +low % of CD4 T cells in GALT become productively infected and are directly killed by HIV-mediated cytolysis/apoptosis +many resting CD4 T cells are killed indirectly by pyroptosis +~80% of CD4 T cells in GALT are depleted in the 1st 3wks of HIV infection \*CD4 T cell counts return to ~normal levels in blood, but not in GALT - Virus incompletely cleared by the immune response- **viral set point**
35
The importance of dendritic cells to the establishment of HIV infection
- HIV stored in endocytic vesicles following entry via DC-SIGN; released via exocytosis - Productive infection of DCs; released via budding - HIV bound to DC-SIGN on surface of DC - Concentration of virions in the vicinity of CD4+ T cells - DCs present HIV peptides through MHC class II molecules to the TCR, resulting in T cell activation \*activates HIV gene transcription
36
Loss of CD4 T cells
- Highest rate of CD4 T cell death occurs during primary infection - HIV-induced cytolysis correlates w/CD4 levels on cells \*monocytes express less CD4 on their surface than T cells and are less easily killed (persisten, productive infection) - X4 viruses are more cytopathic than R5 viruses - Cell-mediated killing \*clears productively infected cells, not latently infected cells
37
Stages of HIV infection Graph
38
Immune response to HIV
39
ARC vs AIDS
- AIDS-related complex (ARC) \*lymphadenopathy, fever, weight loss, malaise \*opportunistic infections, diarrhea, fatigue - AIDS \*CD4 T cell counts \<200/microliters; viral load \>75,000 copies/ml \*AIDS-defining illnesses +HIV wasting syndrome +Kaposi's sarcoma +opportunistic infections +HIV-assoc. dementia (HAD)